Latest Standards Updates
Six New Revision Bulletins (posted 29–May–2020)
One New Publication Announcement (posted 29–May–2020)
One Updated Publication Announcement (posted 29–May–2020)
One New General Announcement (posted 29–May–2020)
One New General Chapter Prospectus (posted 29–May–2020; input deadline 28–Jun–2020)
Seven New Pending Notices of Intent to Revise (posted 29–May–2020)
Cumulative List Updated (posted 29–May–2020)
Three New Reference Change Notices (posted 22–May–2020)
One New Revision Bulletin (posted 18–May–2020)
200 years of building trust
The United States Pharmacopeia (USP) was created nearly 200 years ago, dedicated to instilling trust where it matters most: in the medicines, supplements and foods people rely on for their health. The quality standards we develop help manufacturers deliver on their promises of safe products, while building confidence among healthcare practitioners, patients and consumers.
FDA Commissioner welcomes USP Convention Members
Commissioner Hahn reflects on the FDA’s shared history with USP to improve public health and protect patient safety, including current efforts to combat COVID-19.
Building a More Resilient Supply Chain Requires Transparency, Diversity, and Collaboration
USP CEO highlights COVID-19’s impact on the supply of quality medicines, and solutions for improving manufacturing diversity and data transparency to strengthen the global supply chain.